Company Data

Y-mAbs Therapeutics Inc.

Ticker
YMAB
Current Price
$8.61
Market Cap
$391.2M
Price Target
Refer to Report
Volume
18.0K
52wk Range
$3.55 - $16.11
Advanced Market Data

Overview

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Its pipeline covers Naxitamab, Omburtamab, GD2-GD3 Vaccine, and others.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy